Advances in the Pathogenesis and Treatment of AIDS
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cell Biology and Pathology".
Deadline for manuscript submissions: 30 April 2024 | Viewed by 203
Special Issue Editor
Special Issue Information
Dear Colleagues,
HIV is a viral infection that leads to AIDS, a condition characterized by a compromised immune system, rendering individuals more susceptible to infections and cancer. Worldwide, it is estimated that more than 39 million people are living with HIV infection, two thirds of whom (25.6 million) are in the WHO African Region. In 2022, 630,000 [480,000–880,000] people died from AIDS and 1.3 million [1.0–1.7 million] people acquired HIV. Although antiretroviral therapy (ART) has provided a dramatic reduction in HIV-related morbidity and mortality, many issues are still current and deserve timely resolution considering the ambitious targets (95–95–95) formulated by the World Health Organization by 2025. Among the challenges that still require effort through both basic and clinical research, we can include: access to healthcare in developing countries with a reduction in AIDS-related mortality, detection of the underground of infections, strategies to eradicate infections on a global scale, optimizations of antiretroviral therapies, deterrminants of virological failure, implementation of new regimen long-acting injectables, personalization and tailoring of ART, and improvement of the quality of life in people living with HIV (PLWH). The purpose of this Special Issue is to gather both basic and clinical research experiences that can underscore the undeniable progress in the pathogenesis and treatment of AIDS. We welcome both research articles and reviews.
Dr. Giuseppe Bruno
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antiretroviral therapy
- pathogenesis
- AIDS
- opportunistic infections
- long-acting strategies
- new targets for HIV
- pre-exporsure prophylaxis (Prep)
- eradication
